Back
LYFE SCIENCES
Project: HERA
NM_000051.4:c.2333A>G
p.Asn778Ser  ·  ATM
Starting
Initialising…
0%
Legacy Engine
Processing…
Classification rationale
1

The ATM c.2333A>G (p.Asn778Ser; p.N778S) variant has not been observed in somatic cancers in COSMIC and has been reported in ClinVar with mixed germline classifications, including 8 submissions as uncertain significance and 2 as likely benign.

clinvar ↗
2

This variant is present in gnomAD v4.1 at 0.000867% (14/1,613,972 alleles; 0 homozygotes), and this is below the ATM PM2_Supporting threshold of less than or equal to 0.001%.

gnomad_v4 ↗ cspec ↗
3

A high-confidence ATM supplementary functional table classified this variant as functional, but the reviewed ATM-specific materials did not provide a direct mapping of that result to BS3 or PS3 strength.

cspec ↗
4

The REVEL score is 0.099, which is below the ATM PP3 threshold of greater than 0.7333 and within the BP4 missense range of less than or equal to 0.249, but no SpliceAI score was returned, so computational evidence was insufficient to apply BP4 and does not support PP3.

spliceai ↗ cspec ↗
Applied criteria
Met
Not met
Not assessed
N/A
Very strong
Strong
Moderate
Supporting
Pathogenic evidence
PVS
PVS1
PS
PS1
PS2
PS3
PS4
PM
PM1
PM2
PM3
PM4
PM5
PM6
PP
PP1
PP2
PP3
PP4
PP5
Benign evidence
BA
BA1
BS
BS1
BS2
BS3
BS4
BP
BP1
BP2
BP3
BP4
BP5
BP6
BP7
PVS1
Rationale
Select a criterion to inspect its explanation.
Evidence used
Gaps remaining
Rule
Publications
Research and evidence
gnomAD v2.1 evidence
v2.1
gnomAD v4.1 evidence
v4.1
01
Population
gnomAD v2.1This variant is present in gnomAD v2.1 (AF= 1.19346e-05; MAF= 0.00119%, 3/251370 alleles, homozygotes = 0) and has highest observed frequency in the European (non-Finnish) population (AF= 2.63806e-05; MAF= 0.00264%, 3/113720 alleles, homozygotes = 0); grpmax FAF= 7.01e-06.
gnomAD v4.1This variant is present in gnomAD v4.1 (AF= 8.67425e-06; MAF= 0.00087%, 14/1613972 alleles, homozygotes = 0) and has highest observed frequency in the Remaining individuals population (AF= 1.60036e-05; MAF= 0.00160%, 1/62486 alleles, homozygotes = 0); grpmax FAF= 6.15e-06.
ClinVar evidence
02
ClinVar
This variant has been reported in ClinVar as Uncertain significance (8 clinical laboratories) and as Likely benign (2 clinical laboratories).
Functional evidence
03
Functional
OncoKB: Unknown Oncogenic Effect
OncoKB has not reviewed this specific variant; no variant-level oncogenicity or biological effect is available. Gene-level context: ATM, a kinase involved in the DNA damage response, is mutated in various solid and hematologic malignancies.
COSMIC evidence
05
COSMIC
This variant does not lie in a statistically significant hotspot. This variant has not previously been reported in somatic cancers (COSMIC).
Cancer hotspots evidence
06
Cancer hotspots Not found
This variant does not lie in a statistically significant hotspot.
ResidueN778